Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-17 · accession 0001079973-25-001047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-20 | 2025-06-17 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +159.5K | 1.94M | +9% | $0 |
| DI | 2025-06-20 | 2025-06-18 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | +620.4K | 2.56M | +32% | $0 |
| DI | 2025-06-20 | 2025-06-18 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | -6,204 | 0 | -100% | $0 |
| D | 2025-06-20 | 2025-06-17 | STLN | BARASCH RICHARD A | Dir | C - Cnv Deriv | $0.00 | -1,595 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-17 | C | A | 159,500 | $0.00 | 1,935,141 | D By Trust | — | — | (F2) Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion. (F3) Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein. |
| 2 | Common | Common Stock | 2025-06-18 | C | A | 620,400 | $0.00 | 2,555,541 | I | — | — | (F2) Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion. |
| 3 | Derivative | Class A Common Equivalent Preferred Stock | 2025-06-18 | C | D | 6,204 | $0.00 | 0 | I | $0.00 · — to — | 620,400 Common Stock | (F2) Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion. (F4) Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date. |
| 4 | Derivative | Class A Common Equivalent Preferred Stock | 2025-06-17 | C | D | 1,595 | $0.00 | 0 | D By Trust | $0.00 · — to — | 159,500 Common Stock | (F3) Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein. (F2) Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion. (F4) Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date. |